# Cannabis and Mental Health: A Review

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-and-mental-health-risk-review/
> **Published:** 2026-03-24T16:12:03-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:40:45-04:00
> **Clinical Summary:** Explore the cannabis and mental health risk with this clinical review highlighting evidence, benefits, and potential harms of cannabis use in mental health.

---

CED Clinical Relevance  #77Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
🔬 Evidence Watch  |  CED Clinic
Mental HealthAnxietyPtsdCbdThc

Journal
JAMA internal medicine

Study Type
Clinical Study

Population
Human participants

Why This Matters

This comprehensive review addresses a critical clinical gap where patients increasingly self-medicate mental health conditions with cannabis despite limited evidence. The findings provide essential guidance for risk-benefit discussions that occur daily in clinical practice.

Clinical Summary
This systematic review examined evidence for cannabis in treating mental health conditions including PTSD, anxiety, depression, and ADHD. The authors found low-certainty evidence that THC-predominant cannabis does not improve PTSD symptoms, with largely insufficient evidence for other conditions. Emerging low-certainty evidence suggests CBD alone may reduce anxiety in [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/). The review emphasizes substantial risks of adverse mental health effects from THC-predominant cannabis use.

Dr. Caplan’s Take

“This review confirms what I observe clinically – patients often have unrealistic expectations about cannabis for mental health while underestimating risks. The distinction between CBD and THC effects is crucial for informed clinical decision-making.”

Clinical Perspective
🧠 Clinicians should counsel patients that current evidence does not support THC-predominant cannabis for mental health conditions and may cause harm. For [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) specifically, CBD-only products warrant consideration with appropriate monitoring, while maintaining evidence-based treatments as first-line therapy.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20and%20Mental%20Health%3A%20A%20Review.%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41801216/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41801216/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20and%20Mental%20Health%3A%20A%20Review.%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41801216/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41801216/](https://pubmed.ncbi.nlm.nih.gov/41801216/)

Table of Contents

- [FAQ](#FAQ)[Is cannabis effective for treating PTSD symptoms?](#Is_cannabis_effective_for_treating_PTSD_symptoms)
- [Can CBD help with anxiety disorders?](#Can_CBD_help_with_anxiety_disorders)
- [What are the mental health risks of THC-predominant cannabis use?](#What_are_the_mental_health_risks_of_THC-predominant_cannabis_use)
- [Is there evidence supporting cannabis use for depression and ADHD?](#Is_there_evidence_supporting_cannabis_use_for_depression_and_ADHD)
- [Should I recommend cannabis to patients with mental health conditions?](#Should_I_recommend_cannabis_to_patients_with_mental_health_conditions)
- [Related](#Related)

## FAQ

#### Is cannabis effective for treating PTSD symptoms?

Current evidence suggests THC-predominant cannabis may not improve PTSD symptoms, with only low-certainty evidence available. Clinicians should be aware that despite patient reports of symptom relief, robust scientific support for cannabis as a [PTSD treatment](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/) is lacking.

#### Can CBD help with anxiety disorders?

There is emerging low-certainty evidence that cannabidiol (CBD) alone may reduce anxiety in patients with anxiety disorders. However, more research is needed to establish definitive clinical recommendations and optimal dosing protocols.

#### What are the mental health risks of THC-predominant cannabis use?

THC-predominant cannabis use carries substantial risk for adverse mental health effects. Clinicians should counsel patients about these risks, particularly given the insufficient evidence for [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) in most mental health conditions.

#### Is there evidence supporting cannabis use for depression and ADHD?

There is largely insufficient evidence to characterize the effects of long-term THC-predominant cannabis use on depression and ADHD symptoms. The potential benefits for these conditions remain poorly studied despite common patient use.

#### Should I recommend cannabis to patients with mental health conditions?

Given the lack of clear benefits and potential for substantial adverse effects, cannabis should not be routinely recommended for mental health conditions. Clinicians should prioritize evidence-based treatments while remaining informed about emerging research on specific cannabinoids like CBD.

{“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Cannabis and Mental Health: A Review.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41801216/”, “about”: “jama internal medicine clinical study cannabis”, “isPartOf”: “JAMA internal medicine”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Review Finds Limited Evidence For Cannabis In Treating Mental Health Disorders](https://cedclinic.com/limited-evidence-cannabis-mental-health-review/)

This review explores the limited evidence supporting cannabis use for [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/), emphasizing the need for cautious clinical application.

[Read the Review](https://cedclinic.com/limited-evidence-cannabis-mental-health-review/)

[Research Suggests Cannabis Is Ineffective for Depression, Anxiety or PTSD](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/)

A research summary highlighting the ineffectiveness of cannabis for common mental health conditions such as depression, anxiety, and PTSD.

[Explore the Research](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/)

[Is Cannabis Effective for Treating Mental Health Disorders? – Labroots](https://cedclinic.com/cannabis-mental-health-treatment-challenges/)

An analysis discussing the effectiveness and limitations of cannabis in treating various [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/).

[Learn More](https://cedclinic.com/cannabis-mental-health-treatment-challenges/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
